Dr. Adrian Harel (Finland) has served as CEO, owner or founder of more than nine life sciences and biotech companies. He holds more than 12 patents, and is a frequent contributor in scientific publications.
His current company Medicortex designed an entire pipeline of neuroprotective drugs and biomarkers for brain injury. They are currently developing a rapid diagnostic kit for the detection of TBI, multifunctional drug molecules for the treatment of TBI and halting the cellular deterioration initiated by TBI. See medicortex.fi for more.